Sr VP, CFO of Theravance Inc. (THRX) Michael W Aguiar sells 24,682 shares of THRX on 08/27/2012 at an average price of $27.44 a share.

Theravance Inc has a market cap of $2.7 billion; its shares were traded at around $27.08 with and P/S ratio of 110.33.

This is the annual revenues and earnings per share of THRX over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of THRX.

CEO Recent Trades:

• CEO Rick E Winningham sold 75,749 shares of THRX stock on 08/03/2012 at the average price of 27.95. Rick E Winningham owns at least 591,258 shares after this. The price of the stock has decreased by 3.11% since.

CFO Recent Trades:

• Sr VP, CFO Michael W Aguiar sold 60,000 shares of THRX stock on 08/07/2012 at the average price of 27.04. Michael W Aguiar owns at least 157,924 shares after this. The price of the stock has increased by 0.15% since.
• Sr VP, CFO Michael W Aguiar sold 20,000 shares of THRX stock on 05/29/2012 at the average price of 22.29. Michael W Aguiar owns at least 157,924 shares after this. The price of the stock has increased by 21.49% since.

This is the insider trade history vs. stock price of THRX. For the complete insider trading history of THRX, click here.

Directors and Officers Recent Trades:

• 10% Owner Plc Glaxosmithkline bought 316,334 shares of THRX stock on 08/03/2012 at the average price of 28.21. Plc Glaxosmithkline owns at least 26,130,755 shares after this. The price of the stock has decreased by 4.01% since.
• 10% Owner Plc Glaxosmithkline bought 10,000,000 shares of THRX stock on 05/16/2012 at the average price of 21.29. Plc Glaxosmithkline owns at least 25,814,421 shares after this. The price of the stock has increased by 27.2% since.
• SVP, Research & Early Clin Dev Mathai Mammen sold 25,000 shares of THRX stock on 08/13/2012 at the average price of 25.74. Mathai Mammen owns at least 212,285 shares after this. The price of the stock has increased by 5.21% since.
• Head of Business Dev. David L Brinkley sold 123,917 shares of THRX stock on 08/03/2012 at the average price of 27.92. David L Brinkley owns at least 66,781 shares after this. The price of the stock has decreased by 3.01% since.
• Director Jeffrey M Drazan sold 8,586 shares of THRX stock on 05/01/2012 at the average price of 21.71. Jeffrey M Drazan owns at least 33,465 shares after this. The price of the stock has increased by 24.74% since.

For the complete insider trading history of THRX, click here.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool